Results 71 to 80 of about 719 (136)

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer. [PDF]

Cancer Gene Ther
Bandi DSR, Sarvesh S, Foote J, Welsch D, Cheng C, Akce M, Nagaraju GP, El-Rayes BF, El-Rayes BF.   +8 more
europepmc   +1 more source

The Effect of Vitamin D Supplementation on the Length of Hospitalisation, Intensive Care Unit Admission, and Mortality in COVID-19-A Systematic Review and Meta-Analysis. [PDF]

Nutrients, 2023
Sîrbu AC, Sabin O, Bocșan IC, Vesa ȘC, Buzoianu AD.   +4 more
europepmc   +1 more source

Vitamin D and melanoma: an umbrella meta-analysis of serum levels, dietary intake, and VDR polymorphisms. [PDF]

J Transl Med
Jiang B, Li Y, Zhong W, Zou Y, Chen B, Yu B.   +5 more
europepmc   +1 more source

Perirenal fat differs in patients with chronic kidney disease receiving different vitamin D-based treatments: a preliminary study. [PDF]

BMC Nephrol
Checa-Ros A, Locascio A, Okojie OJ, Abellán-Galiana P, D'Marco L.   +4 more
europepmc   +1 more source

Editorial: the role of vitamin D metabolites in the evaluation of bone health: are they physiologically relevant? [PDF]

J Bone Miner Res
Liu ES, LeBoff MS.
europepmc   +1 more source

Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease. [PDF]

J Bras Nefrol, 2023
Ponce D, Cardoso MMA, Rúgolo JRM, Molina SA, Andrade LGM, Curado DDSP.   +5 more
europepmc   +1 more source

Vitamin D Supplementation Improves Muscle Mass, Physical Function, and Quality of Life in Patients With Degenerative Lumbar Disease. [PDF]

Clin Transl Sci
Dechsupa S, Yingsakmongkol W, Limthongkul W, Singhatanadgige W, Assawakosri S, Honsawek S.   +5 more
europepmc   +1 more source

Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease. [PDF]

J Vet Intern Med
Chen H, Segev G, Mazaki-Tovi M.
europepmc   +1 more source

Vitamin D receptor modulates autophagy via miR-20a-5p/ATG16L1 axis to alleviate lipopolysaccharide-induced acute kidney injury. [PDF]

Ren Fail
Wei Y, Du D, Xie X, He J, Li N, Li Z, Zhang H, Zhang W.   +7 more
europepmc   +1 more source

ROS-responsive graphene-hyaluronic acid nanomedicine for targeted therapy in renal ischemia/reperfusion injury. [PDF]

Theranostics
Lee S, Suh SH, Ma SK, Kim J, Park S, Kim SW, Lee JY.   +6 more
europepmc   +1 more source